Purple Biotech News

HC Wainwright & Co. Maintains Buy on Purple Biotech, Adjusts Price Target To $33 (1-20 Reverse Stock Split)

BenzingaSep 21 01:39

Purple Biotech Analyst Ratings

BenzingaSep 21 01:34

H.C. Wainwright Maintains Purple Biotech(PPBT.US) With Buy Rating, Cuts Target Price to $33

Futu NewsSep 19 18:31

Analysts Offer Insights on Healthcare Companies: Purple Biotech (PPBT) and Aligos Therapeutics (ALGS)

TipRanksAug 20 16:13

Purple Biotech Analyst Ratings

BenzingaAug 19 19:44

Purple Biotech Analyst Ratings

BenzingaJul 12 01:25

HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $10 Price Target

BenzingaJul 12 01:25

Promising Phase 2 Results for Purple Biotech's CM24 in Pancreatic Cancer Treatment Bolster Buy Rating

TipRanksJul 12 00:20

Buy Rating Justified by Purple Biotech's Promising Clinical Data and Market Potential

TipRanksMay 21 23:50

HC Wainwright & Co. : The Purple Biotech (PPBT.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.

Zhitong FinanceMay 21 23:40

Purple Biotech Analyst Ratings

BenzingaMay 21 23:40

HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $10 Price Target

BenzingaMay 21 23:40

HC Wainwright & Co. : The Purple Biotech (PPBT.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $10.00.

Zhitong FinanceApr 27 02:30

Purple Biotech Analyst Ratings

BenzingaApr 27 02:25

HC Wainwright & Co. Reiterates Buy on Purple Biotech, Maintains $10 Price Target

BenzingaApr 27 02:25

Purple Biotech Analyst Ratings

BenzingaMar 8 03:00

Purple Biotech Analyst Ratings

BenzingaMar 6 01:10

Promising Pipeline Prospects for Purple Biotech: Buy Rating Affirmed Amidst Anticipated Clinical Advancements

TipRanksMar 6 00:41

Purple Biotech Analyst Ratings

BenzingaFeb 28 01:44

Buy Rating Justified by Promising Phase 1 Results of Purple Biotech's NT219 in SCCHN Treatment

TipRanksFeb 28 01:25